FRANKLIN RESOURCES INC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$383,247
+1.8%
8,449
-7.9%
0.00%
Q2 2023$376,286
+1.2%
9,171
-11.8%
0.00%
Q1 2023$371,696
-28.3%
10,400
-24.2%
0.00%
Q4 2022$518,166
+4.3%
13,719
+21.9%
0.00%
Q3 2022$497,000
+138.9%
11,251
+205.6%
0.00%
Q4 2020$208,000
-98.2%
3,682
-98.5%
0.00%
-100.0%
Q3 2020$11,500,000
-21.1%
242,351
+0.9%
0.01%
-25.0%
Q2 2020$14,575,000
+28.1%
240,230
-0.2%
0.01%0.0%
Q1 2020$11,379,000
-28.5%
240,673
-8.7%
0.01%0.0%
Q4 2019$15,924,000
+0.8%
263,6000.0%0.01%
-11.1%
Q3 2019$15,792,000
-6.8%
263,6000.0%0.01%0.0%
Q2 2019$16,942,000
-50.1%
263,600
-36.9%
0.01%
-50.0%
Q1 2019$33,929,000
+320.7%
418,000
+180.2%
0.02%
+260.0%
Q4 2018$8,065,000
-68.1%
149,180
-69.6%
0.01%
-61.5%
Q3 2018$25,303,000
-15.3%
490,574
-31.6%
0.01%
-13.3%
Q2 2018$29,878,000
-8.4%
717,016
-3.1%
0.02%
-11.8%
Q1 2018$32,608,000
-13.6%
739,756
-1.5%
0.02%
-5.6%
Q4 2017$37,759,000
-19.7%
750,666
-19.0%
0.02%
-21.7%
Q3 2017$46,997,000
-8.9%
926,968
-8.6%
0.02%
-11.5%
Q2 2017$51,586,000
+19.9%
1,014,064
-5.2%
0.03%
+18.2%
Q1 2017$43,015,000
-16.6%
1,070,034
-0.6%
0.02%
-18.5%
Q4 2016$51,573,000
+34.1%
1,076,534
+2.6%
0.03%
+35.0%
Q3 2016$38,464,000
+52.3%
1,049,714
-3.2%
0.02%
+42.9%
Q2 2016$25,253,000
-64.8%
1,084,367
-38.8%
0.01%
-63.2%
Q1 2016$71,743,000
-35.3%
1,771,447
-1.1%
0.04%
-32.1%
Q4 2015$110,964,0001,791,7470.06%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders